Enhanced CAR T-cell engineering using non-viral Sleeping Beauty transposition from minicircle vectors
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Enhanced CAR T-cell engineering using non-viral Sleeping Beauty transposition from minicircle vectors
Authors
Keywords
-
Journal
LEUKEMIA
Volume 31, Issue 1, Pages 186-194
Publisher
Springer Nature
Online
2016-08-05
DOI
10.1038/leu.2016.180
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients
- (2016) Cameron J. Turtle et al. JOURNAL OF CLINICAL INVESTIGATION
- Gene Insertion Into Genomic Safe Harbors for Human Gene Therapy
- (2016) Eirini P Papapetrou et al. MOLECULAR THERAPY
- Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor
- (2015) James N. Kochenderfer et al. JOURNAL OF CLINICAL ONCOLOGY
- Adoptive cellular therapy: A race to the finish line
- (2015) Carl H. June et al. Science Translational Medicine
- Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T Cells
- (2015) M. J. Frigault et al. Cancer Immunology Research
- CD19-CAR Trials
- (2014) Carlos A. Ramos et al. CANCER JOURNAL
- Adoptive Therapy With Chimeric Antigen Receptor–Modified T Cells of Defined Subset Composition
- (2014) Stanley R. Riddell et al. CANCER JOURNAL
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Specific HIV integration sites are linked to clonal expansion and persistence of infected cells
- (2014) F. Maldarelli et al. SCIENCE
- Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
- (2014) M. L. Davila et al. Science Translational Medicine
- Chromatin Landscapes of Retroviral and Transposon Integration Profiles
- (2014) Johann de Jong et al. PLoS Genetics
- The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for In Vivo Antitumor Activity
- (2014) M. Hudecek et al. Cancer Immunology Research
- Receptor Affinity and Extracellular Domain Modifications Affect Tumor Recognition by ROR1-Specific Chimeric Antigen Receptor T Cells
- (2013) M. Hudecek et al. CLINICAL CANCER RESEARCH
- A new approach to gene therapy usingSleeping Beautyto genetically modify clinical-grade T cells to target CD19
- (2013) Harjeet Singh et al. IMMUNOLOGICAL REVIEWS
- Comparison of Lentiviral and Sleeping Beauty Mediated αβ T Cell Receptor Gene Transfer
- (2013) Anne-Christine Field et al. PLoS One
- Manufacture of Clinical-Grade CD19-Specific T Cells Stably Expressing Chimeric Antigen Receptor Using Sleeping Beauty System and Artificial Antigen Presenting Cells
- (2013) Harjeet Singh et al. PLoS One
- Efficient Sleeping Beauty DNA Transposition From DNA Minicircles
- (2013) Nynne Sharma et al. Molecular Therapy-Nucleic Acids
- Minicircle DNA electrotransfer for efficient tissue-targeted gene delivery
- (2012) S Chabot et al. GENE THERAPY
- Performance of High Quality Minicircle DNA for In Vitro and In Vivo Gene Transfer
- (2012) Dennis Kobelt et al. MOLECULAR BIOTECHNOLOGY
- Retargeting Sleeping Beauty Transposon Insertions by Engineered Zinc Finger DNA-binding Domains
- (2012) Katrin Voigt et al. MOLECULAR THERAPY
- A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells
- (2011) X. Wang et al. BLOOD
- TheSleeping Beautytransposon system for clinical applications
- (2011) Marta Swierczek et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- The hyperactive Sleeping Beauty transposase SB100X improves the genetic modification of T cells to express a chimeric antigen receptor
- (2011) Z Jin et al. GENE THERAPY
- Translating Sleeping Beauty transposition into cellular therapies: Victories and challenges
- (2010) Zsuzsanna Izsvák et al. BIOESSAYS
- The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor
- (2010) M. Hudecek et al. BLOOD
- Comparative Analysis of Transposable Element Vector Systems in Human Cells
- (2010) Ivana Grabundzija et al. MOLECULAR THERAPY
- Gene Transfer Efficiency and Genome-Wide Integration Profiling of Sleeping Beauty, Tol2, and PiggyBac Transposons in Human Primary T Cells
- (2010) Xin Huang et al. MOLECULAR THERAPY
- Genomic safe harbors permit high β-globin transgene expression in thalassemia induced pluripotent stem cells
- (2010) Eirini P Papapetrou et al. NATURE BIOTECHNOLOGY
- A robust system for production of minicircle DNA vectors
- (2010) Mark A Kay et al. NATURE BIOTECHNOLOGY
- Efficient nonviral Sleeping Beauty transposon-based TCR gene transfer to peripheral blood lymphocytes confers antigen-specific antitumor reactivity
- (2009) P D Peng et al. GENE THERAPY
- Analysis of Lentiviral Vector Integration in HIV+ Study Subjects Receiving Autologous Infusions of Gene Modified CD4+ T Cells
- (2009) Gary P Wang et al. MOLECULAR THERAPY
- Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates
- (2009) Lajos Mátés et al. NATURE GENETICS
- Redirecting Specificity of T-Cell Populations For CD19 Using the Sleeping Beauty System
- (2008) H. Singh et al. CANCER RESEARCH
- Dynamic Regulation of Nucleosome Positioning in the Human Genome
- (2008) Dustin E. Schones et al. CELL
- Minicircle-DNA production by site specific recombination and protein-DNA interaction chromatography
- (2008) Peter Mayrhofer et al. JOURNAL OF GENE MEDICINE
- Sleeping Beauty Transposon‐mediated Engineering of Human Primary T Cells for Therapy of CD19+ Lymphoid Malignancies
- (2008) Xin Huang et al. MOLECULAR THERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now